Subscribe to the BioNews newsletter for free

Login
Advanced Search

Search for
BioNews

Like the Progress Educational Trust on Facebook


Human Clinical Embryology and Assisted Conception MSc


 

HIV edited out of T cells using CRISPR

04 April 2016

By Dr Lanay Tierney

Appeared in BioNews 845

Scientists have used the CRISPR genome-editing technique to remove HIV from the DNA of infected T cells and prevent reinfection. 

Building on earlier research that removed HIV from cultured cells (see BioNews 764), the researchers successfully treated infected cells from AIDS patients, and they hope that the technique could be developed into a treatment for the disease.

The HIV retrovirus inserts itself permanently into the genome of infected cells and, while anti-retroviral therapy (ART) is able to control HIV infection, it can only lower the viral load, not eliminate it. Copies of HIV can persist in other tissues and, if ART is stopped, the infection can reassert itself.

'Therefore, most HIV-1-infected individuals, even those who respond very well to ART must maintain lifelong ART due to persistence of HIV-1-infected reservoir cells,' said Professor Kamel Khalili, director of the Center for Neurovirology at Temple University in Philadelphia and lead author of the study, which was published in Scientific Reports.

Professor Khalili's team had previously used the CRISPR/Cas9 genome-editing technique to 'cut out' HIV from various immune cells in culture. In this study they performed the same technique on infected CD4+ T cells taken from the blood HIV-positive patients.

They were able to not only eliminate the virus but also protect the cell from reinfection with HIV because the CRISPR machinery was left inside the cell. Importantly, the team did not detect any off-target effects, meaning that only the HIV was edited out and no other parts of the genome were inadvertently modified. The cleared cells appeared to grow and function normally.

'The findings are important on multiple levels,' said Professor Khalili. 'They demonstrate the effectiveness of our gene-editing system in eliminating HIV from the DNA of CD4+ T-cells and, by introducing mutations into the viral genome, permanently inactivate viral replication. Further, they show that the system can protect cells from reinfection and that the technology is safe for the cells, with no toxic effects.'

Professor Khalili told Voice of America that human clinical trials could get underway in two to three years.

SOURCES & REFERENCES
Scientific Reports | 04 March 2016
 
Voice of America | 25 March 2016
 
Gizmodo | 22 March 2016
 
UPI | 21 March 2016
 
Temple University (press release) | 21 March 2016
 

RELATED ARTICLES FROM THE BIONEWS ARCHIVE

08 May 2017 - by Emma Laycock 
US scientists have used CRISPR gene-editing to remove HIV DNA from the genomes of living animals, eliminating further infection.
11 April 2016 - by James Brooks 
Scientists testing whether the CRISPR genome-editing technique could effectively kill HIV in infected cells have found that, while the approach works in most cases, it can also cement the virus's presence...
11 April 2016 - by Ayala Ochert 
A second team in China report that they have created genetically modified human embryos, in an attempt to make them resistant to HIV, using the genome-editing technique CRISPR/Cas9...

07 March 2016 - by Kirsty Oswald 
Researchers have found that mimiviruses, a class of giant viruses, have an immune system reminiscent of the CRISPR system used by bacteria to evade infection...
03 August 2015 - by Lubna Ahmed 
Researchers have successfully used the technique CRISPR/Cas 9 to cut and paste genes into T-cells of the immune system...
01 June 2015 - by Dr Lanay Tierney 
Part of a gene that protects against the progression of HIV in humans has been identified in Tanzanian chimps...
28 July 2014 - by Dr James Heather 
Research has shown that it may be possible to 'cut' the viral DNA out of cells infected by HIV using genetic editing techniques, removing its ability to replicate...
28 January 2013 - by Matthew Thomas 
Altering the genetic makeup of immune cells could provide them with resistance to HIV...

HAVE YOUR SAY
Be the first to have your say.

You need to or  to add comments.

By posting a comment you agree to abide by the BioNews terms and conditions


- click here to enquire about using this story.

Published by the Progress Educational Trust
Advertise your products and services HERE - click for further details

Good Fundraising Code

Become a Friend of PET HERE and give the Progress Educational Trust a regular donation